Maa: Malesia
Kieli: englanti
Lähde: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
MOXIFLOXACIN
EUCOGEN SDN BHD
MOXIFLOXACIN
20 x 250 ml
HK inno. N Corporation
pharmacist prior to continuing treatment if symptoms of neuropathy such as pain, burning, tingling, numbness, or weakness develop in order to prevent the development of potentially irreversible condition (see section Undesirable Effects). PSYCHIATRIC REACTIONS Psychiatric reactions may occur even after the first administration of fluoroquinolones, including moxifloxacin. In very rare cases depression or psychotic reactions have progressed to suicidal thoughts and self-injurious behavior such as suicide attempts (see “ _Undesirable effects_ ”). In the event that the patient develops these reactions, MOVELOXIN should be discontinued and appropriate measures instituted. Caution is recommended if MOVELOXIN is to be used in psychotic patients or in patients with a history of psychiatric disease. GENITAL TRACT INFECTIONS Because of the widespread and rising prevalence of fluoroquinolone-resistant _Neisseria gonorrhoeae_ infections, monotherapy with moxifloxa- cin should be avoided in patients with pelvic inflammatory disease, unless fluoroquinolone-resistant _N. gonorrhoeae_ can be excluded. If fluoroquinolone-resistant _N. gonorrhoeae_ can not be excluded, the addition of an appropriate antibiotic which is regularly active against _N. _ _gonorrhoeae_ (e.g., a cephalosporin) to empirical moxifloxacin therapy, should be considered. DYSGLYCEMIA As with all fluoroquinolones, disturbances in blood glucose, including both hypoglycemia and hyperglycemia have been reported with MOVELOXIN. In MOVELOXIN-treated patients, dysglycemia occurred predominantly in elderly diabetic patients receiving concomitant treatment with an oral hypoglycemic agent (e.g. sulfonylurea) or with insulin. In diabetic patients, careful monitoring of blood glucose is recommended (see “ _Undesirable effects_ ”). INFORMATION ABOUT EXCIPIENTS In patients for whom sodium intake is of medical concern (patients with congestive heart failure, renal failure, nephrotic syndrome, etc.) the additional sodium load of the solution for infusion should be tak Lue koko asiakirja